Shorter, stronger treatment tested in fight against rectal cancer
NCT ID NCT05673772
Summary
This study is testing a new treatment plan for rectal cancer that hasn't spread to distant organs. It compares a shorter course of radiation followed by four cycles of chemotherapy (FOLFOX) against the standard longer chemoradiation, both given before surgery. The goal is to see if the new approach improves survival by treating hidden cancer cells earlier. All patients will have surgery after their pre-surgery treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
, Korea University Anam Hospital
Seoul, South Korea
-
Asan Medical Center
Seoul, 05505, South Korea
-
Catholic University of Korea Incheon St. Mary's Hospital
Incheon, South Korea
-
Chonnam National University Hwasun Hospital
Gwangju, South Korea
-
Chungnam National University Hospital
Daejeon, South Korea
-
Gangnam Severance Hospital
Seoul, South Korea
-
Gyu seog Choi
Daegu, 702-210, South Korea
-
Jeonbuk National University Hospital
Jeonju, South Korea
-
Seoul National University Bundang Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.